通过 κ-阿片类受体-G 蛋白质复合体的逆激素的分子机制
Aaliyah S Tyson1,2, Saif Khan1,3, Zenia Motiwala1,3,4
1The Bridge Institute, Michelson Center for Convergent Biosciences, University of Southern California, Los Angeles, CA, USA.
Nature chemical biology
|January 8, 2025
概括
某些卡帕阿片类受体 (KOR) 反向激素激活了G蛋白信号传递,而没有激素. 这挑战了对G蛋白结合受体 (GPCR) 反对性的传统理解,并揭示了新的药理学见解.
科学领域:
- 药理学 药理学是指药理学的学科.
- 结构生物学 结构生物学
- 生物化学 生物化学
背景情况:
- 阿片类受体是一种G蛋白结合受体 (GPCR),是关键的药物标.
- 传统模型指出,激动剂激活GPCRs,而抗剂通过阻止G蛋白合来阻止激活.
- 然而,GPCRs可以具有基底活性,即使没有激动剂,也可以与G蛋白形成复合体,这种现象具有不清楚的药理学意义.
研究的目的:
- 为了研究卡帕阿片类受体 (KOR) 逆agonists的作用机制.
- 探索无激动剂的KOR-G蛋白质复合物的作用和结构.
- 挑战GPCR对抗的正规模型.
主要方法:
- 确定了KOR-Gi蛋白质复合物的冷电子显微镜 (cryo-EM) 结构.
- 使用了三种逆激动剂:JDTic,norBNI和GB18.
- 分析了与逆agonist结合的GPCR-G蛋白质复合物的结构和生化特性.
主要成果:
- 证明特定的KOR逆agonists可以通过KOR-Gi蛋白质复合体调解活性.
- 观察到,这些复合体中的 Orthosteric 结合口袋模仿了不活跃的,没有 G 蛋白质的受体构造.
- 发现该受体仍然与G蛋白结合,尽管反向激动剂结合和非活性类型的口袋形状.
结论:
- 这项研究挑战了GPCRs受体对抗的既定模型.
- 通过预先形成的受体-G蛋白质复合体提供逆激素活性的生化证据.
- 提供了对GPCR复杂药理及其与G蛋白相互作用的重要见解.
相关概念视频
Opioid Receptors: Overview
501
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
501
Drug-Receptor Interaction: Agonist
2.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.3K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
GPCR Desensitization
5.8K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.8K
Analgesia and Pain Management
490
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
490
GPCRs Regulate Adenylyl Cylase Activity
5.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.3K


